Personalized medicine: what is it and what are the challenges?

Personalized and precision medicine requires new approaches to studying optimal treatment approaches.

0
0

Volume 109, Issue 6, Pages 944–945

Authors:

Mark Sigman, M.D

Abstract:

Personalized medicine and precision medicine are presenting new opportunities for better patient care, but also present unique challenges. The traditional randomized clinical trial is not necessarily the most appropriate approach to evaluating what may be the best treatment for an individual. Alternative study designs pose unique regulatory challenges for the U.S. Food and Drug Administration but offer the opportunity for higher response rates. Ovarian stimulation for assisted reproductive technology offers opportunities for personalized and more precise approaches to individual patient care.


Read the full text here.


Go to the profile of Fertility and Sterility

Fertility and Sterility

Editorial Office, American Society for Reproductive Medicine

Fertility and Sterility® is an international journal for obstetricians, gynecologists, reproductive endocrinologists, urologists, basic scientists and others who treat and investigate problems of infertility and human reproductive disorders. The journal publishes juried original scientific articles in clinical and laboratory research relevant to reproductive endocrinology, urology, andrology, physiology, immunology, genetics, contraception, and menopause. Fertility and Sterility® encourages and supports meaningful basic and clinical research, and facilitates and promotes excellence in professional education, in the field of reproductive medicine.

No comments yet.